Finance

Lists
0009K0:KOSDAQ
Aimed Bio Inc
â‚©27,250.00
+0.74%
(+200.00) 1D
Aug 14, 3:30:25 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 0009K0...
Open
â‚©26,950
High
â‚©27,600
Low
â‚©26,350
Mkt. cap
1.76T
Avg. vol.
168.49K
Volume
0.00
P/E ratio
33.73
52-wk high
â‚©80,200
52-wk low
â‚©17,400
EPS
â‚©808
Shares outstanding
64.67M
Open
â‚©26,950
High
â‚©27,600
Low
â‚©26,350
Mkt. cap
1.76T
Avg. vol.
168.49K
Volume
0.00
P/E ratio
33.73
52-wk high
â‚©80,200
52-wk low
â‚©17,400
EPS
â‚©808
Shares outstanding
64.67M
About Aimed Bio Inc
CEO-
Employees-
Founded2018
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Mar 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.58B
114.24M
37.98B
8.50B
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
298.57M
-
-904.24M
666.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.08B
5.98B
13.00B
11.36B
Operating expense
2.71B
5.98B
12.46B
12.46B
Total operating expenses
2.71B
5.98B
12.46B
12.46B
Operating income
-1.13B
-5.87B
25.52B
-3.96B
Other non operating income
-105.95M
665.52M
5.60M
-17.17M
EBT including unusual items
-1.06B
-5.20B
25.74B
-2.01B
EBT excluding unusual items
-970.75M
-5.20B
25.76B
-978.49M
Income tax expense
-
-
-9.18B
-
Effective tax rate
-
-
-35.67%
-
Other operating expenses
-
-
-
-
Net income
-1.06B
-5.20B
34.92B
-2.01B
Net profit margin
-67.14%
-4,549.74%
91.95%
-23.66%
Earnings per share
-
-
-
-
Interest and investment income
283.84M
-
673.31M
1.31B
Interest expense
-13.59M
-
-23.82M
-55.28M
Net interest expenses
270.24M
-
649.49M
1.25B
Depreciation and amortization charges
262.20M
-
284.77M
355.26M
EBITDA
-797.33M
-5.52B
25.88B
-3.53B
Gain or loss from assets sale
-
-
16.22M
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps